Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Befotertinib (D-0316) is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 397.00 | |
25 mg | In stock | $ 663.00 | |
50 mg | In stock | $ 945.00 | |
100 mg | In stock | $ 1,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 272.00 |
Description | Befotertinib (D-0316) is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer. |
Synonyms | D-0316, Befotertinib |
Molecular Weight | 567.61 |
Formula | C29H32F3N7O2 |
CAS No. | 1835667-63-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (105.71 mM), ultrasonic and warming and heat to 60°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Befotertinib 1835667-63-4 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR lung Epidermal growth factor receptor D-0316 ErbB-1 Inhibitor D0316 HER1 inhibit cancer kinase tyrosine non-small NSCLC D 0316 inhibitor